The recombinant atpE is produced in E. coli and purified via affinity chromatography (His tag). Post-purification steps include:
Form: Lyophilized powder in Tris/PBS-based buffer with 6% trehalose.
Storage: -20°C/-80°C (avoid repeated freeze-thaw cycles).
Reconstitution: Suggested in sterile water (0.1–1.0 mg/mL) with optional glycerol addition for stability .
The recombinant atpE is primarily used in:
Biochemical Assays: Studying ATP synthase assembly and proton translocation.
Antibody Development: Served as an antigen in ELISA kits for immunological studies .
Vaccine Research: While not directly tested, ATP synthase subunits are potential targets for bacterial vaccines due to their conserved nature.
Critical guidelines include:
Storage: -20°C/-80°C; aliquot for repeated use.
Reconstitution: Avoid prolonged exposure to deionized water; add glycerol (5–50%) for long-term storage .
Avoid: Repeated freeze-thaw cycles; store working aliquots at 4°C for ≤1 week .
Current data focus on structural and production aspects, with limited insights into:
Pathogenic Role: Contribution to P. multocida virulence or host-pathogen interactions.
Therapeutic Potential: Utility as a vaccine candidate or drug target.
Further studies are needed to elucidate its immunogenicity and functional importance in disease models.
KEGG: pmu:PM1489
STRING: 272843.PM1489
ATP synthase subunit c (atpE) in Pasteurella multocida is a critical component of the F-type ATP synthase complex, specifically part of the Fo sector (membrane-embedded portion). The protein functions within a ring structure (c-ring) that rotates during proton translocation across the membrane, driving the synthesis of ATP in the F1 sector of the complex. The atpE protein in P. multocida consists of 84 amino acids with the sequence METVITTTIIASAILLAVAALGTALGFAILGGKFLESSARQPELASSLQIKMFIVAGLLD AISMIAVGIALLFIFANPFIDLLK, forming a predominantly hydrophobic structure suited to its membrane-embedded location . This protein is essential for energy metabolism in P. multocida, making it both a significant research target and potential therapeutic target.
Recombinant P. multocida atpE protein is typically expressed using E. coli expression systems due to their efficiency and scalability. The full-length protein (amino acids 1-84) is commonly expressed with an N-terminal histidine tag to facilitate purification. The expression construct typically contains the atpE gene sequence optimized for E. coli codon usage, inserted into an expression vector with an inducible promoter .
For purification, the following methodology is generally employed:
Cell lysis using mechanical disruption or detergent-based methods
Initial capture using immobilized metal affinity chromatography (IMAC) exploiting the His-tag
Further purification may involve ion exchange or size exclusion chromatography
The final product is typically lyophilized and stored as a powder
Reconstitution recommendations include:
Brief centrifugation before opening to bring contents to the bottom
Reconstitution in deionized sterile water to 0.1-1.0 mg/mL
Addition of 5-50% glycerol (typically 50%) for long-term storage at -20°C/-80°C
The most effective expression system for producing functional recombinant P. multocida atpE protein is E. coli, particularly BL21(DE3) strains, as demonstrated in multiple studies . This system offers several advantages:
Expression System | Advantages | Limitations | Yield |
---|---|---|---|
E. coli BL21(DE3) | High expression levels, cost-effective, rapid growth | Potential for inclusion body formation | >90% purity achievable |
TOP10 E. coli | Good for toxic proteins, tighter expression control | Lower yields than BL21 | Variable |
M. smegmatis | Better for mycobacterial membrane proteins | Slower growth, more complex | Not typically used for P. multocida atpE |
For optimal expression in E. coli:
Use vectors with strong inducible promoters (pET28a is commonly used)
Include N-terminal His-tag for purification
Optimize induction conditions (temperature, inducer concentration, duration)
Consider codon optimization for E. coli if expression levels are low
Use Tris/PBS-based buffer systems with 6% trehalose at pH 8.0 for storage
The functional activity of the expressed protein should be verified through ATP hydrolysis assays or reconstitution into liposomes to confirm proton translocation capabilities.
Maintaining the structural integrity and activity of recombinant P. multocida atpE protein requires careful attention to storage conditions. Based on experimental data, the following protocol is recommended:
Initial Storage: Store lyophilized powder at -20°C/-80°C upon receipt
Reconstitution: Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Long-term Storage: Add glycerol to a final concentration of 50% and store in aliquots at -20°C/-80°C
Working Storage: For short-term use, store working aliquots at 4°C for up to one week
Avoid repeated freeze-thaw cycles as they significantly reduce protein activity
The storage buffer composition significantly impacts stability:
Buffer Component | Concentration | Purpose |
---|---|---|
Tris/PBS base | Standard | Maintains pH |
Trehalose | 6% | Acts as cryo-protectant |
pH | 8.0 | Optimal for stability |
Research indicates that protein activity decreases by approximately 15-20% after one freeze-thaw cycle, highlighting the importance of proper aliquoting before freezing. For experiments requiring membrane protein functionality, reconstitution into lipid vesicles immediately before use may provide better preservation of functional properties than storage in detergent solutions.
Site-directed mutagenesis of P. multocida atpE provides powerful insights into proton translocation mechanisms and c-ring rotation dynamics. Based on comparative studies with other bacterial ATP synthases, particularly research on Bacillus PS3 FoF1 with hetero cE56D mutations, the following methodological approach is recommended:
Target conserved residues involved in proton binding, particularly the equivalent of E56 in P. multocida atpE
Create single and double mutations at varying distances in the c-ring using a genetically fused single-chain construct
Assess ATP synthesis/hydrolysis activities of mutants compared to wild-type
Research with Bacillus PS3 demonstrates that ATP synthesis activity decreases with cE56D mutations, with greater reduction observed as the distance between mutation sites increases . This suggests cooperative interactions between c-subunits during ring rotation.
For P. multocida atpE studies, researchers should:
Identify the conserved glutamate residue essential for proton binding (analogous to E56 in Bacillus PS3)
Generate mutations (particularly E→D) at this position in one or more c-subunits
Create a single-chain fusion protein containing 10 copies of atpE to control the number and position of mutations
Perform biochemical assays to measure ATP synthesis/hydrolysis rates
Combine with molecular dynamics simulations to correlate functional effects with structural changes
This approach reveals that at least three c-subunits at the a/c interface cooperate during c-ring rotation, with proton uptake timing shared between adjacent subunits . The experimental evidence suggests that for optimal ATP synthase function, the proton waiting time must be properly coordinated among multiple c-subunits.
Effective structural modeling of P. multocida atpE for inhibitor studies requires a multi-faceted approach combining homology modeling, molecular dynamics (MD) simulations, and docking studies. Based on successful approaches used for mycobacterial atpE inhibitor studies, the following methodology is recommended:
Homology Model Construction:
Validation of the Structural Model:
Ramachandran plot analysis
RMSD comparison with template
Assessment of stereochemical parameters
Normal mode analysis to evaluate protein flexibility
Inhibitor Docking and Interaction Analysis:
Identify the binding cleft (typically at the interface of two protomers)
Perform molecular docking using Glide or AutoDock
Analyze molecular interactions using tools like Arpeggio
Focus on key interaction residues (equivalent to E61, A62, Y64, F65 from one protomer and I66 from adjacent protomer in mycobacterial AtpE)
Resistance Prediction:
Implement machine learning models (such as multilayer perceptron neural networks) trained on known resistance mutations
Evaluate effects of mutations on protein stability using SDM, mCSM-Stability, and DUET
Assess impacts on protein-protein interactions using mCSM-PPI
This comprehensive approach has successfully identified bedaquiline resistance mechanisms in mycobacterial AtpE and can be adapted for P. multocida atpE studies with potential inhibitors.
Mutations in P. multocida atpE can significantly alter ATP synthase function and potentially confer resistance to antimicrobials targeting this protein. Based on studies of atpE in related systems, particularly mycobacterial ATP synthase, the following mechanisms and assessment methodologies are relevant:
Key Mutation Sites and Their Effects:
Mutations in the conserved proton-binding glutamate residue directly impact proton translocation efficiency
Mutations at the interface between adjacent c-subunits can disrupt cooperative rotation
Mutations in the drug binding cleft (formed by residues from adjacent protomers) may confer resistance to inhibitors
Functional Assessment Methods:
ATP synthesis/hydrolysis assays comparing wild-type and mutant enzymes
Proton pumping assays using pH-sensitive fluorescent dyes
Rotation assays using single-molecule techniques
Antimicrobial Resistance Mechanisms:
Reduced binding affinity for the inhibitor
Alterations in proton translocation that bypass inhibitor effects
Structural changes affecting the drug binding pocket
A comprehensive assessment should include:
Mutation Type | Assessment Method | Expected Effect |
---|---|---|
Proton-binding site | ATP synthesis assays | Decreased ATP synthesis activity |
Interface residues | Proton translocation efficiency | Disrupted c-ring rotation |
Drug binding pocket | Inhibitor binding assays | Potential resistance development |
Machine learning approaches have proven valuable for predicting resistance mutations, using features such as:
Structural consequences on protein folding and stability
Effects on protein flexibility and conformation
Impacts on protein-protein interactions between protomers
These predictive models can guide experimental studies and antimicrobial development strategies targeting P. multocida atpE.
Comparative analysis of P. multocida atpE with other bacterial species reveals important structural and functional distinctions that inform experimental approaches. The following comparison highlights key differences:
Species | Sequence Identity (%) | c-ring Stoichiometry | Key Structural Differences | Functional Implications |
---|---|---|---|---|
P. multocida | 100 (reference) | Predicted 10 | 84 amino acids, UniProt ID: Q9CKW5 | Standard reference |
M. phlei | ~85 | 9 | Crystal structure available (PDB: 4V1F) | Suitable homology model template |
Mycobacterium tuberculosis | ~70 | 9 | Bedaquiline binding site characterized | Drug resistance mechanisms known |
Bacillus PS3 | ~60 | 10 | Well-studied c10 fusion protein | Cooperative rotation mechanisms |
E. coli | ~50 | 10 | Lower conservation in membrane regions | Different inhibitor sensitivity |
Functional differences include:
Proton binding site specificity: While the essential glutamate residue is conserved, the surrounding amino acids that determine proton affinity and translocation kinetics vary
c-ring stoichiometry: Affects the bioenergetic efficiency (H+/ATP ratio)
Inhibitor sensitivity: Different species show varying susceptibility to ATP synthase inhibitors
For experimental approaches, researchers should consider:
Using M. phlei atpE as a structural template due to high sequence identity (~85%)
Applying insights from Bacillus PS3 studies on cooperative c-ring rotation
Employing comparative mutagenesis to identify species-specific functional regions
These differences have significant implications for antimicrobial development and understanding energy metabolism across bacterial species.
Advanced biophysical techniques provide critical insights into the structure, dynamics, and function of recombinant P. multocida atpE. The following methodologies are particularly informative:
Cryo-Electron Microscopy (Cryo-EM):
Enables visualization of the entire ATP synthase complex
Resolves the c-ring structure in its native membrane environment
Sample preparation: Purified protein reconstituted in nanodiscs or native membrane fragments
Resolution: Currently achievable to 2.5-3.5 Å for membrane protein complexes
Solid-State Nuclear Magnetic Resonance (ssNMR):
Provides atomic-level insights into structure and dynamics
Particularly valuable for membrane proteins in lipid bilayers
Requires isotopically labeled protein (13C, 15N)
Can detect conformational changes during proton translocation
Hydrogen/Deuterium Exchange Mass Spectrometry (HDX-MS):
Maps solvent accessibility and protein dynamics
Identifies regions involved in conformational changes during function
Does not require protein crystallization
Can be performed in various lipid environments
Single-Molecule Fluorescence Resonance Energy Transfer (smFRET):
Directly measures rotational dynamics of the c-ring
Requires strategic placement of fluorophores on c and a subunits
Provides real-time kinetic information during ATP synthesis/hydrolysis
Molecular Dynamics Simulations:
For optimal results, a combination of these techniques should be employed:
These advanced techniques, when used in combination, provide comprehensive insights into P. multocida atpE structure-function relationships that cannot be achieved through biochemical assays alone.
Recombinant P. multocida atpE serves as a valuable target for antimicrobial development, offering several strategic research applications:
High-Throughput Screening (HTS) Platforms:
Reconstitute purified atpE into liposomes with ATP synthase activity indicators
Develop fluorescence-based assays monitoring proton translocation
Screen compound libraries against the reconstituted protein
Validate hits using whole-cell ATP synthesis inhibition assays
Structure-Based Drug Design:
Utilize homology models based on high-identity templates like M. phlei atpE
Identify druggable pockets at subunit interfaces
Design compounds targeting the conserved proton binding site
Focus on the binding cleft formed by residues equivalent to E61, A62, Y64, F65 from one protomer and I66 from adjacent protomer
Resistance Prevention Strategies:
Implement machine learning models to predict potential resistance mutations
Design drugs that maintain efficacy against predicted resistant variants
Target highly conserved regions essential for function
Develop combination therapies targeting multiple sites on ATP synthase
Rational Modification of Existing Inhibitors:
Use bedaquiline as a starting scaffold for modification
Optimize interactions with P. multocida-specific residues
Address known resistance mechanisms from other bacterial species
Balance membrane permeability with target affinity
A systematic approach for antimicrobial development should include:
Stage | Methodology | Key Considerations |
---|---|---|
Target Validation | Gene knockout/knockdown studies | Essentiality for bacterial survival |
Primary Screening | ATP synthesis inhibition assays | Activity, selectivity over mammalian ATP synthase |
Lead Optimization | Structure-based design | Binding site specificity, resistance profile |
Resistance Profiling | Selection of resistant mutants | Cross-resistance to other antibiotics |
Preclinical Assessment | Animal infection models | Efficacy, pharmacokinetics, toxicity |
This comprehensive strategy leverages structural and functional knowledge of P. multocida atpE to develop novel antimicrobials with reduced resistance potential.
Research on P. multocida atpE faces several significant challenges while offering promising future directions for bacterial bioenergetics and antimicrobial development:
Current Challenges:
Structural Characterization:
Obtaining high-resolution structures of the complete P. multocida ATP synthase
Capturing different conformational states during the catalytic cycle
Reconstituting the protein in native-like membrane environments
Functional Studies:
Establishing reliable assays for proton translocation in reconstituted systems
Measuring the kinetics of c-ring rotation at the single-molecule level
Correlating structural features with bioenergetic efficiency
Species-Specific Research:
Limited P. multocida-specific studies compared to model organisms
Translating findings from other bacterial species to P. multocida
Understanding species-specific adaptations in ATP synthase function
Future Research Directions:
The field would benefit from focused research in these areas:
Research Area | Potential Impact | Technical Requirements |
---|---|---|
Cryo-EM structures | Define species-specific features | Advanced sample preparation |
Single-molecule studies | Clarify mechanism of rotation | Fluorescent labeling strategies |
Computational simulations | Predict resistance mutations | Integration with experimental data |
Directed evolution | Engineer optimal properties | High-throughput screening platforms |
Addressing these challenges will significantly advance our understanding of bacterial bioenergetics while providing new avenues for antimicrobial development targeting this essential system.